Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

Conditions:   SLE (Systemic Lupus);   Sjogren's Syndrome;   Systemic Scleroderma;   Dermatomyositis;   Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Intervention:   Biological: CD19 targeted CAR-T cells Sponsor:   Chongqing Precision Biotech Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials